Beximco Pharmaceuticals (DHA:BXPHARMA) Additional Paid-In Capital : BDT6,959 Mil(As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Beximco Pharmaceuticals Additional Paid-In Capital?

Beximco Pharmaceuticals's quarterly additional paid-in capital stayed the same from Jun. 2023 (BDT6,959 Mil) to Dec. 2023 (BDT6,959 Mil) and stayed the same from Dec. 2023 (BDT6,959 Mil) to Mar. 2024 (BDT6,959 Mil).

Beximco Pharmaceuticals's annual additional paid-in capital stayed the same from Jun. 2021 (BDT6,959 Mil) to Jun. 2022 (BDT6,959 Mil) and stayed the same from Jun. 2022 (BDT6,959 Mil) to Jun. 2023 (BDT6,959 Mil).

Beximco Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for Beximco Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Additional Paid-In Capital Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Additional Paid-In Capital

Get a 7-Day Free Trial

6,959.11

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															6,959.11	6,959.11	6,959.11	6,959.11	6,959.11

Beximco Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Beximco Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (DHA:BXPHARMA) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

BXP:UK R2WA:Germany

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.

Beximco Pharmaceuticals (DHA:BXPHARMA) Headlines

No Headlines